100% Quality Guarantee
PhD-Level Technical Support
Key Features

Plozalizumab Biosimilar (CCR2) Antibody (HDBS0080)

SKU HDBS0080
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CCR2
Reactivity Human
Host Species Humanized
Isotype IgG1
$569

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Plozalizumab Biosimilar (CCR2) Antibody (HDBS0080)

The Plozalizumab Biosimilar CCR2 Antibody offered by Assay Genie is a cutting-edge tool for research involving C-C chemokine receptor type 2 (CCR2), a key player in inflammation and immune responses. This biosimilar antibody, produced through advanced biotechnology processes, demonstrates high specificity and sensitivity in binding to CCR2 in human samples, enabling precise detection and analysis in various experimental settings.CCR2 is a chemokine receptor involved in recruiting inflammatory cells to sites of injury or infection, making it a crucial target for understanding and potentially modulating immune responses in conditions such as cancer, autoimmune disorders, and inflammatory diseases.

The Plozalizumab Biosimilar Anti-CCR2 Antibody provides researchers with a reliable tool to investigate the role of CCR2 in these diseases, offering new insights into potential therapeutic strategies.With its exceptional performance in assays like Western blotting, this biosimilar antibody facilitates accurate and reproducible data in immunology and cancer research studies. Its versatility and reliability make it a valuable asset for scientists aiming to unravel the complexities of CCR2-mediated pathways and explore new avenues for therapeutic intervention. Trust in the Plozalizumab Biosimilar Anti-CCR2 Antibody from Assay Genie for your cutting-edge research needs.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose